GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,700 MG PER 170 ML (10 MG/ML)
LIVE

Serial Number

88125503

Owner

SUN PHARMACEUTICAL INDUSTRIES LIMITED

Attorney

Craig Kuchii, Esq.

First Use Date

Jul 8, 2020

Filing Date

Sep 20, 2018

Add to watchlist:

No watchlists yet
View on USPTO

GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,700 MG PER 170 ML (10 MG/ML) Trademark

Serial Number: 88125503 • Registration: 6217216

GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,700 MG PER 170 ML (10 MG/ML) is a trademark filed by SUN PHARMACEUTICAL INDUSTRIES LIMITED on September 20, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

SUN PHARMACEUTICAL INDUSTRIES LIMITED (296 trademarks)

VADODARA, GUJARAT 390012 , IN

Entity Type: 16

Trademark Details

Filing Date

September 20, 2018

Registration Date

December 8, 2020

First Use Anywhere

July 8, 2020

First Use in Commerce

July 8, 2020

Published for Opposition

February 26, 2019

Goods & Services

medical apparatus, namely, infusion devices for administering drugs in the nature of ready-to-use infusion bags containing medicinal and pharmaceutical preparations of gemcitabine

medicinal and pharmaceutical preparations packed in ready to use infusion bags for chemotherapy, reduction of tension and anxiety, improvement of heart function, correction of hemodynamic imbalances present in the shock syndrome, blood pressure control in certain acute hypotensive states and for intravenous induction of general anesthesia or before administration of other anesthetic, all of the foregoing comprising gemcitabine; medicinal and pharmaceutical preparations packed in ready to use infusion bags for treatment of cancer, pain, diseases related to central nervous system, epilepsy, ventricular tachycardia or ventricular fibrillation, irregular heartbeat, angina, blood pressure and gynecological disorders, all of the foregoing comprising gemcitabine

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 8, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Dec 8, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Nov 4, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 3, 2020 CNPR
SOU TEAS EXTENSION RECEIVED
Oct 23, 2020 EEXT
STATEMENT OF USE PROCESSING COMPLETE
Oct 13, 2020 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 13, 2020 AITU
USE AMENDMENT FILED
Sep 29, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
Sep 29, 2020 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 24, 2020 EXRA
SOU EXTENSION 2 GRANTED
Apr 22, 2020 EX2G
SOU EXTENSION 2 FILED
Apr 22, 2020 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 22, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 25, 2019 EXRA
SOU EXTENSION 1 GRANTED
Oct 23, 2019 EX1G
SOU EXTENSION 1 FILED
Oct 23, 2019 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 23, 2019 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 23, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 26, 2019 NPUB
PUBLISHED FOR OPPOSITION
Feb 26, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 6, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 18, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 15, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 15, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 15, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 15, 2019 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jan 14, 2019 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jan 8, 2019 PBCR
ASSIGNED TO LIE
Dec 21, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 29, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 29, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 29, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 29, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 29, 2018 CNEA
ASSIGNED TO EXAMINER
Nov 27, 2018 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 27, 2018 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 26, 2018 NWOS
NEW APPLICATION ENTERED
Sep 24, 2018 NWAP